Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
Podcast: The Long Run with Luke TimmermanPublished On: Mon Jan 31 2022
Description: Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.
The note was deleted
The note was saved
Your message was sent